Stock listing
NASDAQ:FLXN Flexion Therapeutics Inc Stock
Follow Flexion Therapeutics Inc into a list and get an email when it puts out news.
Last close · NASDAQ:FLXN
$9.12 USD
Close on Nov 19, 2021 · No longer trades
- Lowest – highest close
- $4.40 – $29.93 USDSince Feb 12, 2014 · lowest Aug 19, 2021 · highest Oct 6, 2017
Delisted NASDAQ:FLXN no longer trades. Its last trading date is unknown. Company history and updates stay available on this page.
- Ticker
- NASDAQ:FLXN
- Asset type
- Stock
- Exchange
- NASDAQ
- Currency
- USD
Flexion Therapeutics Inc on 6ix
- Decks
- 13 decks · latest Aug 4, 2021
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2021 Earnings Presentation | Earnings | 5 slides | Aug 4, 2021 |
| Q1 2021 Earnings Presentation | Earnings | 5 slides | May 12, 2021 |
| Technical Presentation (May 2021) | Technical | 10 slides | May 11, 2021 |
| Q1 2021 Earnings Presentation | Earnings | 7 slides | Apr 13, 2021 |
| Q4 2020 Earnings Presentation | Earnings | 7 slides | Jan 13, 2021 |
| Q3 2020 Earnings Presentation | Earnings | 7 slides | Oct 13, 2020 |
| Q2 2020 Earnings Presentation | Earnings | 7 slides | Jul 14, 2020 |
| Q1 2020 Earnings Presentation | Earnings | 7 slides | May 7, 2020 |
| Q4 2019 Earnings Presentation | Earnings | 7 slides | Mar 12, 2020 |
| Q3 2019 Earnings Presentation | Earnings | 7 slides | Nov 7, 2019 |
All 13 decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Q2 2019 Earnings Presentation | Earnings | 7 slides | Aug 6, 2019 |
| Q1 2019 Earnings Presentation | Earnings | 8 slides | May 8, 2019 |
| Technical Presentation (April 2016) | Technical | 10 slides | Apr 4, 2016 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Brian Atwood Other companies: CERo Therapeutics Holdings, Inc. (Director · Since at least Oct 5, 2021); Launch One Acquisition Corp. (Director · Jul 11, 2024 – Jul 11, 2024 · Past); Atreca Inc (Director · Jun 19, 2019 – Jun 13, 2023 · Past); CapForce Inc. (Director · May 4, 2015 – Jun 22, 2016 · Past); Immune Design Corp (Director · Jul 23, 2014 – Jan 4, 2016 · Past); Veracyte, Inc. (Director · Oct 29, 2013 – Jun 20, 2016 · Past); Five Prime Therapeutics Inc (Director · Sep 17, 2013 – Jun 12, 2015 · Past); Clovis Oncology Inc (Director · Nov 15, 2011 – Jun 10, 2021 · Past); Trius Therapeutics Inc (Director · Aug 2, 2010 – Sep 11, 2013 · Past); Cadence Pharmaceuticals Inc (Director · Oct 24, 2006 – Mar 19, 2014 · Past); Pharmion Corp (Director · Jun 8, 2006 – Mar 7, 2008 · Past) | Director · Sep 10, 2014 – Sep 10, 2014 · Past |
| Frederick W. Driscoll Other companies: Lite Strategy, Inc. (Chairperson, Non-Executive Director · Since at least Feb 22, 2018); Cellectar Biosciences, Inc. (Director · Since at least Apr 10, 2017); Invivyd, Inc. (Interim CFO · Oct 13, 2022 – Oct 13, 2022 · Past); ConforMIS Inc (INTERIM CFO & INTERIM TREAS · Oct 23, 2019 – Oct 23, 2019 · Past); Cue Biopharma, Inc. (Director · Jun 26, 2018 – Jan 2, 2025 · Past); ImmunityBio, Inc. (Director · Sep 18, 2017 – Aug 11, 2020 · Past); Oncotelic Therapeutics Inc (Director · Jan 1, 2014 – Jun 1, 2016 · Past); Novavax, Inc. (VP, CFO & Treasurer · Aug 24, 2009 – Mar 2, 2013 · Past); Genelabs Technologies Inc (CEO/PRESIDENT · Nov 1, 2007 – Jan 7, 2009 · Past) | Chief Financial Officer · Feb 11, 2014 – Nov 19, 2021 · Past |
| William J. Link Other companies: RxSight, Inc. (Director · Since at least Jul 29, 2021); Tarsus Pharmaceuticals, Inc. (Director · Since at least Oct 15, 2020); LENSAR, Inc. (Director · Since at least Sep 17, 2020); Oyster Point Pharma Inc (Director · Oct 30, 2019 – Jan 5, 2022 · Past); Glaukos Corporation (Director · Jun 24, 2015 – Jun 3, 2021 · Past); Vivani Medical, Inc. (Director · Nov 18, 2014 – Jun 4, 2019 · Past); Inogen, Inc (Director · Feb 12, 2014 – Feb 20, 2014 · Past); Edwards Lifesciences Corporation (Director · May 15, 2013 – May 8, 2020 · Past) | Director · Sep 10, 2014 – Sep 10, 2014 · Past |
| Samuel D Colella Other companies: Veracyte, Inc. (Director · Oct 29, 2013 – May 20, 2014 · Past); Standard BioTools Inc. (Director · Feb 9, 2011 – Mar 10, 2020 · Past); Jazz Pharmaceuticals plc (Director · May 31, 2007 – Jan 11, 2012 · Past); Solta Medical Inc (Director · Nov 9, 2006 – Nov 15, 2006 · Past); Genomic Health Inc (Director · May 25, 2006 – Oct 1, 2014 · Past); Symyx Technologies Inc (Director · Apr 4, 2006 – Jun 12, 2007 · Past); Alexza Pharmaceuticals Inc (Director · Mar 8, 2006 – Jul 28, 2011 · Past) | Director · Feb 11, 2014 – Nov 19, 2021 · Past |
| David Arkowitz Other companies: iBio, Inc. (Director · Since at least Nov 21, 2024); Kineta Inc. (Director · Since at least Mar 6, 2019); Seres Therapeutics, Inc. (Chief Financial Officer · Jun 1, 2021 – Feb 14, 2024 · Past); Spring Bank Pharmaceuticals Inc (Director · May 5, 2016 – Jun 24, 2020 · Past); AMAG Pharmaceuticals Inc (EVP, CFO and CBO · Apr 5, 2007 – May 31, 2011 · Past); Idenix Pharmaceuticals Inc (Chief Financial Officer · Mar 7, 2006 – Mar 6, 2007 · Past) | Chief Financial Officer · May 7, 2018 – May 10, 2021 · Past |
| Andrew J Schwab Other companies: CAMP4 Therapeutics Corporation (Director · Since at least Oct 10, 2024); Skye Bioscience, Inc. (Director · Since at least Aug 18, 2023); Enliven Therapeutics, Inc. (Director · Feb 23, 2023 – Feb 23, 2023 · Past); Pear Therapeutics Inc (Director · Dec 3, 2021 – Dec 3, 2021 · Past); 5 01 Acquisition Corp (Co-CEO, Director · Oct 13, 2020 – Nov 30, 2020 · Past) | Director · Feb 11, 2014 – Mar 3, 2014 · Past |
| Scott A Canute Other companies: Oncorus Inc (Director · Dec 11, 2020 – Jun 23, 2022 · Past); Akebia Therapeutics, Inc. (Director · Jun 14, 2018 – Jun 6, 2019 · Past); Protara Therapeutics, Inc. (Director · Jun 8, 2018 – Jun 8, 2018 · Past); Immunomedics Inc (Director · Apr 2, 2018 – Oct 23, 2020 · Past); Outlook Therapeutics, Inc. (Director · Oct 26, 2017 – Oct 26, 2017 · Past) | Director · Jun 20, 2018 – Nov 19, 2021 · Past |
| Mark Stejbach Other companies: Indivior Pharmaceuticals, Inc. (Director · Since at least May 13, 2026); Supernus Pharmaceuticals, Inc. (INDEPENDENT NON-EXECUTIVE DIRECTOR · Since at least Jan 1, 2026); Alkermes plc (SVP/Chief Comm Off, Alks Inc · Feb 29, 2012 – Mar 1, 2018 · Past); Tengion Inc (VP and Chief Commercial Offcr · Apr 9, 2010 – May 11, 2011 · Past) | Director · Sep 13, 2016 – Nov 19, 2021 · Past |
| Patrick Mahaffy Other companies: Medicus Pharma Ltd. (Director · Since at least Aug 29, 2025); Clovis Oncology Inc (See Remarks, Director · Nov 15, 2011 – Mar 1, 2022 · Past); Orexigen Therapeutics Inc (Director · Feb 27, 2009 – Jul 14, 2017 · Past); Pharmion Corp (CEO, President, Director · Mar 2, 2006 – Mar 7, 2008 · Past) | Director · Feb 11, 2014 – Nov 19, 2021 · Past |
| Sandesh Mahatme Other companies: Vor Biopharma Inc. (CFO · Since at least Jul 9, 2025); CRISPR Therapeutics AG (Director · Since at least May 30, 2024); Spyre Therapeutics, Inc. (Director · Apr 6, 2016 – Jun 7, 2022 · Past); Sarepta Therapeutics, Inc. (EVP, CFO & CBO · Nov 5, 2012 – May 11, 2020 · Past) | Director · Jul 22, 2014 – Jun 10, 2020 · Past |
All 32 people
| Person | Seat |
|---|---|
| William T. Andrews Other companies: Catalyst Pharmaceuticals, Inc. (Chief Medical Officer · Since at least Jun 2, 2025); Akcea Therapeutics Inc (Chief Medical Officer · Jul 9, 2020 – Oct 12, 2020 · Past); Acer Therapeutics Inc (Chief Medical Officer · Oct 2, 2017 – Mar 2, 2020 · Past); Aegerion Pharmaceuticals Inc (See Remarks · Mar 29, 2015 – Aug 4, 2015 · Past) | Chief Medical Officer · Jul 1, 2021 – Nov 19, 2021 · Past |
| Alan Milinazzo Other companies: LDR Holding Corp (Director · Jul 9, 2015 – Jul 13, 2016 · Past); CAS Medical Systems Inc (Director · Jun 23, 2015 – Apr 18, 2019 · Past); InspireMD Inc. (President and CEO, Director · Jan 3, 2013 – Jan 29, 2016 · Past) | Director · Feb 11, 2014 – Nov 19, 2021 · Past |
| Arthur Fratamico Other companies: Panbela Therapeutics, Inc. (Director · Dec 1, 2020 – Mar 27, 2023 · Past); Galera Therapeutics, Inc. (Chief Business Officer · Nov 6, 2019 – Jan 26, 2021 · Past); Vitae Pharmaceuticals Inc (Chief Business Officer · Sep 24, 2014 – Oct 24, 2016 · Past) | Chief Business Officer · Feb 11, 2014 – Feb 11, 2014 · Past |
| Bradley J PhD Bolzon Other companies: Monte Rosa Therapeutics, Inc. (Director · Feb 24, 2021 – Jun 28, 2021 · Past); Black Diamond Therapeutics, Inc. (Director · Jan 29, 2020 – Jun 18, 2021 · Past); CRISPR Therapeutics AG (Director · Oct 18, 2016 – Jun 9, 2022 · Past) | Director · Feb 11, 2014 – Sep 10, 2014 · Past |
| C Ann Merrifield Other companies: Lyra Therapeutics, Inc. (Director · Apr 30, 2020 – May 14, 2025 · Past); Juniper Pharmaceuticals Inc (Director · Jul 16, 2015 – Aug 14, 2018 · Past); InVivo Therapeutics Holdings Corp (Director · Nov 8, 2014 – Nov 17, 2022 · Past) | Director · Jun 11, 2014 – Nov 19, 2021 · Past |
| Heath Lukatch Other companies: Vaxcyte, Inc. (Director · Since at least Jun 11, 2020); Satsuma Pharmaceuticals Inc (Director · Sep 12, 2019 – Jun 8, 2023 · Past); Inogen, Inc (Director · Feb 12, 2014 – May 10, 2021 · Past) | Director · Feb 11, 2014 – Nov 19, 2021 · Past |
| Mark S Levine Other companies: 908 Devices Inc. (Chief Legal and Admin. Officer · Since at least Feb 26, 2026); Immunovant, Inc. (Chief Legal Officer · Jan 19, 2022 – Nov 20, 2024 · Past); Minerva Neurosciences, Inc (SVP,General Counsel & Sec. · Aug 14, 2014 – Jun 1, 2017 · Past) | General Counsel · Jun 26, 2017 – Nov 19, 2021 · Past |
| Utpal Koppikar Other companies: Insmed Incorporated (Director · Since at least Oct 19, 2026); C4 Therapeutics, Inc. (Director · Since at least Mar 16, 2022); Atara Biotherapeutics, Inc. (Chief Financial Officer · Jun 7, 2018 – Mar 2, 2023 · Past) | Director · Jul 9, 2021 – Nov 19, 2021 · Past |
| Elizabeth Kwo Other companies: Kestra Medical Technologies, Ltd. (Director · Since at least Sep 3, 2025); Asensus Surgical Inc (Director · Jul 22, 2021 – Aug 22, 2024 · Past) | Director · Aug 18, 2020 – Nov 19, 2021 · Past |
| Kerry Wentworth Other companies: Nuvation Bio Inc. (Chief Regulatory Officer · Since at least May 23, 2022); Agenus Inc. (VP, Clinical, Reg & Qual · Jul 20, 2006 – Feb 26, 2014 · Past) | Chief Regulatory Officer · Dec 21, 2017 – Nov 19, 2021 · Past |
| Ross A Md Jaffe Other companies: Minerva Surgical, Inc. (Director · Oct 21, 2021 – Jun 10, 2022 · Past); Insulet Corporation (Director · May 14, 2007 – Feb 17, 2012 · Past) | Director · Sep 10, 2014 – Sep 10, 2014 · Past |
| Charles Warden Other companies: Ocular Therapeutix, Inc. (Lead Independent Director · Since at least Jul 24, 2014) | Director · Sep 10, 2014 – Sep 10, 2014 · Past |
| Donald B Milder Other companies: Inari Medical Inc (Director · May 21, 2020 – Feb 19, 2025 · Past) | Director · Sep 10, 2014 – Sep 10, 2014 · Past |
| Michael D Clayman Other companies: Akebia Therapeutics, Inc. (Director · Jul 28, 2014 – Jun 14, 2018 · Past) | President and CEO, Director · Feb 11, 2014 – Nov 19, 2021 · Past |
| Scott Kelley Other companies: Aspect Medical Systems Inc (VP and Medical Director · Feb 14, 2006 – Nov 6, 2009 · Past) | Chief Medical Officer · Dec 6, 2017 – Mar 15, 2021 · Past |
| Adam Muzikant | Chief Business Officer · Jan 1, 2021 – Nov 19, 2021 · Past |
| Barbara N Lubash | Director · Sep 10, 2014 – Sep 10, 2014 · Past |
| Christina Willwerth | Chief Strategy Officer · Jan 10, 2019 – Nov 19, 2021 · Past |
| Melissa Layman | Chief Commercial Officer · Mar 12, 2020 – Nov 19, 2021 · Past |
| Neil Bodick | Chief Scientific Officer · Feb 11, 2014 – Jan 3, 2020 · Past |
| Rafael Tordjman | Director · Feb 11, 2014 – Mar 3, 2014 · Past |
| Yamo Deniz | Chief Medical Officer · Apr 3, 2017 – Aug 28, 2017 · Past |
Log in to ask 6ix AI your own questions about Flexion Therapeutics Inc.